Trial Profile
Clinical Trials Insight: 700039184
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 Jan 2010
Price :
$35
*
At a glance
- Drugs XY 4083 (Primary)
- Indications Alzheimer's disease; Attention-deficit hyperactivity disorder; Cognition disorders; Schizophrenia
- Focus Adverse reactions
- Sponsors Xytis
- 28 Nov 2008 New trial record.